These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3029240)

  • 21. Split T-cell tolerance in herpes simplex virus-infected mice and its implication for anti-viral immunity.
    Nash AA; Ashford NP
    Immunology; 1982 Apr; 45(4):761-7. PubMed ID: 6279490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of the in vitro-reactivation of latent herpes simplex virus infection in spinal ganglia: comparison of various immune factors. Brief report.
    von Rheinbaben F; Schneweis KE
    Arch Virol; 1986; 87(3-4):315-9. PubMed ID: 2418807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease.
    Simmons A; Nash AA
    J Virol; 1984 Dec; 52(3):816-21. PubMed ID: 6092713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of interferon-gamma in immunity to herpes simplex virus.
    Yu Z; Manickan E; Rouse BT
    J Leukoc Biol; 1996 Oct; 60(4):528-32. PubMed ID: 8864138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of subviral herpes simplex virus type 1 preparation: protection of mice against intradermal challenge with type 1 and type 2 viruses.
    Slichtová V; Kutinová L; Vonka V
    Arch Virol; 1980; 66(3):207-14. PubMed ID: 6255896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression and enhancement of humoral antibody formation by herpes simplex virus types 1 and 2.
    Nick S; Kampe P; Knoblich A; Metzger B; Falke D
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():1015-24. PubMed ID: 3011967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental immunosuppression induced by herpes simplex virus.
    Cappel R; Henry C; Thiry L
    Arch Virol; 1975; 49(1):67-72. PubMed ID: 172950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herpes simplex virus immunology: problems, progress, and promises.
    Kohl S
    J Infect Dis; 1985 Sep; 152(3):435-40. PubMed ID: 2993439
    [No Abstract]   [Full Text] [Related]  

  • 29. Morphology of central nervous system disease in immunosuppressed mice after peripheral herpes simplex virus inoculation. Trigeminal root entry zone.
    Townsend JJ; Baringer JR
    Lab Invest; 1979 Feb; 40(2):178-82. PubMed ID: 219289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the interrelation of resistance and immunity in a mouse model system of herpes-simplex type 2 infection.
    Armerding D
    Immunobiology; 1982 May; 161(5):415-28. PubMed ID: 6284636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of suppressor T cells in herpes simplex virus-induced immune deviation.
    Whittum JA; Niederkorn JY; McCulley JP; Streilein JW
    J Virol; 1984 Aug; 51(2):556-8. PubMed ID: 6086965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autologous antibody is protective against HSV-1 infection of the immunocompromised mouse.
    Alexander TS; Rosenthal KS
    J Lab Clin Med; 1990 Sep; 116(3):400-7. PubMed ID: 2169516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissemination of herpes simplex virus in nude mice after intracutaneous inoculation and effect of antibody on the course of infection.
    Kino Y; Hayashi Y; Hayashida I; Mori R
    J Gen Virol; 1982 Dec; 63(2):475-9. PubMed ID: 6296289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation by cyclosporin A of murine natural resistance against herpes simplex virus infection. I. Interference with the susceptibility to herpes simplex virus infection.
    Armerding D; Scriba M; Hren A; Rossiter H
    Antiviral Res; 1982 May; 2(1-2):3-11. PubMed ID: 6980627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of neutralizing antibodies and T-cells in pathogenesis of herpes simplex virus infection in congenitally athymic mice.
    Kapoor AK; Buckmaster A; Nash AA; Field HJ; Wildy P
    Immunol Lett; 1982 Nov; 5(5):259-65. PubMed ID: 6984425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute and recurrent herpes simplex in several strains of mice.
    Harbour DA; Hill TJ; Blyth WA
    J Gen Virol; 1981 Jul; 55(Pt 1):31-40. PubMed ID: 6271907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of the immune system in establishment of herpes simplex virus latency--studies using CD4+ T-cell depleted mice.
    Schmidt DS; Eis-Hübinger AM; Schneweis KE
    Arch Virol; 1993; 133(1-2):179-87. PubMed ID: 8240008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).
    Smith PM; Wolcott RM; Chervenak R; Jennings SR
    Virology; 1994 Jul; 202(1):76-88. PubMed ID: 7912023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunity to herpes simplex virus type 2. Suppression of virus-induced immune responses in ultraviolet B-irradiated mice.
    Yasumoto S; Hayashi Y; Aurelian L
    J Immunol; 1987 Oct; 139(8):2788-93. PubMed ID: 2821119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation of herpes simplex virus from the skin of clinically normal mice during latent infection.
    Hill TJ; Harbour DA; Blyth WA
    J Gen Virol; 1980 Mar; 47(1):205-7. PubMed ID: 6245170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.